800-872-2273

Clinical Trials and Studies

Your participation matters. Help us discover and cure!

Contact us at (800) USC-CARE (800-872-2273)

We're sorry, but this trial is no longer enrolling volunteers.

Description

Phase

Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.

Inclusion and Exclusion Criteria

Please contact Sara Villanueva to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.

Sites

  • California

    • GSK Investigational Site, Los Angeles, California, 90033
    • GSK Investigational Site, Beverly Hills, California, 90211
    • GSK Investigational Site, Los Angeles, California, 90035
    • GSK Investigational Site, Bakersfield, California, 93301

  • Nevada

    • GSK Investigational Site, Las Vegas, Nevada, 89106

  • Arizona

    • GSK Investigational Site, Phoenix, Arizona, 85015

  • Texas

    • GSK Investigational Site, El Paso, Texas, 79905
    • GSK Investigational Site, Fort Worth, Texas, 76104
    • GSK Investigational Site, Dallas, Texas, 75235
    • GSK Investigational Site, Dallas, Texas, 75246
    • GSK Investigational Site, Bellaire, Texas, 77401

  • Oklahoma

    • GSK Investigational Site, Oklahoma City, Oklahoma, 73103

  • Nebraska

    • GSK Investigational Site, Omaha, Nebraska, 68198

  • Missouri

    • GSK Investigational Site, Kansas City, Missouri, 64111
    • GSK Investigational Site, St. Louis, Missouri, 63110

  • Iowa

    • GSK Investigational Site, Iowa City, Iowa, 52242

  • Indiana

    • GSK Investigational Site, Indianapolis, Indiana, 46202

  • Georgia

    • GSK Investigational Site, Atlanta, Georgia, 30309
    • GSK Investigational Site, Decatur, Georgia, 30033

  • France

    • GSK Investigational Site, Bobigny, 93009
    • GSK Investigational Site, Paris Cedex 10, 75475
Powered by SC CTSI